Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies

Drugs
J C AdkinsA Markham

Abstract

Fludarabine is an antineoplastic agent which has been studied in patients with a variety of lymphoproliferative malignancies. Clinical evidence from comparative studies in chronic lymphocytic leukaemia (CLL) suggests that fludarabine is at least as effective as CAP (cyclophosphamide, doxorubicin and prednisone) or CHOP (cyclophosphamide, vincristine, doxorubicin and prednisone) in previously treated or chemotherapy-naive patients and significantly more effective than chlorambucil in terms of response rate and duration and survival in chemotherapy-naive patients. Promising results have also been reported with fludarabine-based combination therapy in the treatment of patients with CLL. In addition, sequential therapy with fludarabine and cytarabine has demonstrated good efficacy in the treatment of acute leukaemias, as has fludarabine monotherapy and combination therapy in low grade non-Hodgkin's lymphoma. A favourable cytoreductive response has been reported in patients with lymphoplasmacytoid lymphoma and in a smaller number of patients with cutaneous T cell lymphomas, CLL of T cell origin or prolymphocytic leukaemia. Recent data also support the use of fludarabine, either as a component of a nonmyeloablative conditioning regim...Continue Reading

Citations

Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S CzuczmanS H Bernstein
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A BoogaertsM Klein
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M ForanT A Lister
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J-F RossiS M Tollerfield
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M ForanT A Lister
Jun 14, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Vincent GrégoirePierre Scalliet
Sep 4, 2008·Clinical Lymphoma & Myeloma·Arun Vijay, Morie A Gertz
Jan 15, 2003·Annual Review of Medicine·Florence RoufosseMichel Goldman

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.